MRI and CT coronary angiography in survivors of COVID-19
Trisha Singh, Thomas A Kite, Shruti S Joshi, Nick B Spath, Lucy Kershaw, Andrew Baker, Helen Jordan, Gaurav Singh Gulsin, Michelle Claire Williams, Edwin J R van Beek, Jayanth Ranjit Arnold, Scott I K Semple, Alastair James Moss, David E Newby, Marc Dweck, Gerry P McCann, Trisha Singh, Thomas A Kite, Shruti S Joshi, Nick B Spath, Lucy Kershaw, Andrew Baker, Helen Jordan, Gaurav Singh Gulsin, Michelle Claire Williams, Edwin J R van Beek, Jayanth Ranjit Arnold, Scott I K Semple, Alastair James Moss, David E Newby, Marc Dweck, Gerry P McCann
Abstract
Objectives: To determine the contribution of comorbidities on the reported widespread myocardial abnormalities in patients with recent COVID-19.
Methods: In a prospective two-centre observational study, patients hospitalised with confirmed COVID-19 underwent gadolinium and manganese-enhanced MRI and CT coronary angiography (CTCA). They were compared with healthy and comorbidity-matched volunteers after blinded analysis.
Results: In 52 patients (median age: 54 (IQR 51-57) years, 39 males) who recovered from COVID-19, one-third (n=15, 29%) were admitted to intensive care and a fifth (n=11, 21%) were ventilated. Twenty-three patients underwent CTCA, with one-third having underlying coronary artery disease (n=8, 35%). Compared with younger healthy volunteers (n=10), patients demonstrated reduced left (ejection fraction (EF): 57.4±11.1 (95% CI 54.0 to 60.1) versus 66.3±5 (95 CI 62.4 to 69.8)%; p=0.02) and right (EF: 51.7±9.1 (95% CI 53.9 to 60.1) vs 60.5±4.9 (95% CI 57.1 to 63.2)%; p≤0.0001) ventricular systolic function with elevated native T1 values (1225±46 (95% CI 1205 to 1240) vs 1197±30 (95% CI 1178 to 1216) ms;p=0.04) and extracellular volume fraction (ECV) (31±4 (95% CI 29.6 to 32.1) vs 24±3 (95% CI 22.4 to 26.4)%; p<0.0003) but reduced myocardial manganese uptake (6.9±0.9 (95% CI 6.5 to 7.3) vs 7.9±1.2 (95% CI 7.4 to 8.5) mL/100 g/min; p=0.01). Compared with comorbidity-matched volunteers (n=26), patients had preserved left ventricular function but reduced right ventricular systolic function (EF: 51.7±9.1 (95% CI 53.9 to 60.1) vs 59.3±4.9 (95% CI 51.0 to 66.5)%; p=0.0005) with comparable native T1 values (1225±46 (95% CI 1205 to 1240) vs 1227±51 (95% CI 1208 to 1246) ms; p=0.99), ECV (31±4 (95% CI 29.6 to 32.1) vs 29±5 (95% CI 27.0 to 31.2)%; p=0.35), presence of late gadolinium enhancement and manganese uptake. These findings remained irrespective of COVID-19 disease severity, presence of myocardial injury or ongoing symptoms.
Conclusions: Patients demonstrate right but not left ventricular dysfunction. Previous reports of left ventricular myocardial abnormalities following COVID-19 may reflect pre-existing comorbidities.
Trial registration number: NCT04625075.
Keywords: COVID-19; magnetic resonance imaging.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. 10.1016/S0140-6736(20)30566-3
- Clerkin KJ, Fried JA, Raikhelkar J, et al. . COVID-19 and cardiovascular disease. Circulation 2020;141:1648–55. 10.1161/CIRCULATIONAHA.120.046941
- Guo T, Fan Y, Chen M, et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:811–8. 10.1001/jamacardio.2020.1017
- Smeeth L, Thomas SL, Hall AJ, et al. . Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004;351:2611–8. 10.1056/NEJMoa041747
- Lindner D, Fitzek A, Bräuninger H, et al. . Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol 2020;5:1281–5. 10.1001/jamacardio.2020.3551
- Hu H, Ma F, Wei X, et al. . Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 2021;42:206. 10.1093/eurheartj/ehaa190
- McCracken IR, Saginc G, He L, et al. . Lack of evidence of angiotensin-converting enzyme 2 expression and replicative infection by SARS-CoV-2 in human endothelial cells. Circulation 2021;143:865–8. 10.1161/CIRCULATIONAHA.120.052824
- Kotecha T, Knight DS, Razvi Y, et al. . Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 2021;42:1–13. 10.1093/eurheartj/ehab075
- Pellegrini D, Kawakami R, Guagliumi G, et al. . Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation 2021;143:1031–42. 10.1161/CIRCULATIONAHA.120.051828
- Huang L, Zhao P, Tang D, et al. . Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging 2020;13:2330–9. 10.1016/j.jcmg.2020.05.004
- Puntmann VO, Carerj ML, Wieters I, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1265. 10.1001/jamacardio.2020.3557
- Knight DS, Kotecha T, Razvi Y, et al. . COVID-19: myocardial injury in survivors. Circulation 2020;142:1120–2. 10.1161/CIRCULATIONAHA.120.049252
- Starekova J, Bluemke DA, Bradham WS, et al. . Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol 2021;6:945. 10.1001/jamacardio.2020.7444
- Buzon J, Roignot O, Lemoine S, et al. . Takotsubo cardiomyopathy triggered by influenza A virus. Intern Med 2015;54:2017–9. 10.2169/internalmedicine.54.3606
- Ayoubkhani D, Khunti K, Nafilyan V. Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. medRxiv 2021;27:601–15.
- Nalbandian A, Sehgal K, Gupta A, et al. . Post-Acute COVID-19 syndrome. Nat Med 2021;27:601–15. 10.1038/s41591-021-01283-z
- Spath NB, Singh T, Papanastasiou G, et al. . Manganese-Enhanced magnetic resonance imaging in dilated cardiomyopathy and hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2020:jeaa273. 10.1093/ehjci/jeaa273
- Haimovich AD, Ravindra NG, Stoytchev S, et al. . Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation. Ann Emerg Med 2020;76:442–53. 10.1016/j.annemergmed.2020.07.022
- Papanastasiou G, Williams MC, Kershaw LE, et al. . Measurement of myocardial blood flow by cardiovascular magnetic resonance perfusion: comparison of distributed parameter and Fermi models with single and dual bolus. J Cardiovasc Magn Reson 2015;17:17. 10.1186/s12968-015-0125-1
- Spath NB, Lilburn DML, Gray GA, et al. . Manganese-Enhanced T 1 Mapping in the Myocardium of Normal and Infarcted Hearts. Contrast Media Mol Imaging 2018;2018:1–13. 10.1155/2018/9641527
- Nick S, Trisha S, Giorgos P. Manganese-Enhanced T1 mapping in Non-Ischaemic cardiomyopathy. J Am Coll Cardiol 2020;75.
- Abbara S, Blanke P, Maroules CD, et al. . SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the Society of cardiovascular computed tomography guidelines Committee: endorsed by the North American Society for cardiovascular imaging (NASCI). J Cardiovasc Comput Tomogr 2016;10:435–49. 10.1016/j.jcct.2016.10.002
- Hays GA SH. The heart of the pandemic: insights of CMR imaging in COVID-19. Am Coll Cardiol 2020.
- Ojha V, Verma M, Pandey NN, et al. . Cardiac magnetic resonance imaging in coronavirus disease 2019 (COVID-19): a systematic review of cardiac magnetic resonance imaging findings in 199 patients. J Thorac Imaging 2021;36:73–83. 10.1097/RTI.0000000000000574
- Raman B, Cassar MP, Tunnicliffe EM, et al. . Medium-Term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 2021;31:100683. 10.1016/j.eclinm.2020.100683
- Rodrigues JCL, Amadu AM, Dastidar AG, et al. . Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes. Heart 2016;102:1671–9. 10.1136/heartjnl-2016-309576
- Shang Y, Zhang X, Leng W, et al. . Assessment of diabetic cardiomyopathy by cardiovascular magnetic resonance T1 mapping: correlation with left-ventricular diastolic dysfunction and diabetic duration. J Diabetes Res 2017;2017:1–8. 10.1155/2017/9584278
- Mavrogeni S, Bratis C, Kitsiou A, et al. . CMR assessment of myocarditis in patients with cardiac symptoms during H1N1 viral infection. JACC Cardiovasc Imaging 2011;4:307–9. 10.1016/j.jcmg.2010.08.021
- Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Res 2017;143:142–50. 10.1016/j.antiviral.2017.03.022
Source: PubMed